In two recent presentations from MDACC, a novel risk score that includes grade, and ER, and HER2 status was evaluated in a contemporary patient population who received surgical intervention at MDACC and was then validated in a larger cancer registry confirming the importance of biologic factors in determining prognosis for breast cancer patients48. This evidence concerns the gene ESR1 and breast carcinoma.